文献速递自身免疫性与大疱性皮肤病

低剂量纳曲酮治疗Hailey-Hailey病一例

Low-dose naltrexone: a novel treatment for Hailey-Hailey disease.
PubMed 文献 · Br J Dermatol · 2018-02-23

本文报告一例治疗抵抗的Hailey-Hailey病(慢性良性家族性天疱疮)患者,既往外用及口服糖皮质激素、预防性阿昔洛韦和多西环素以及氨苯砜、阿维A、环孢素等系统治疗均失败。

要点

  • Hailey-Hailey病为罕见遗传性皮肤病,典型表现为间擦部位糜烂,常由轻微创伤或应激诱发。
  • 该例患者对多种外用、口服及系统治疗均抵抗。

研究设计与样本

  • 单例病例报告,报告一例治疗抵抗的Hailey-Hailey病患者。

主要发现

  • 患者既往外用及口服糖皮质激素、预防性阿昔洛韦和多西环素以及氨苯砜、阿维A和环孢素治疗均失败。
  • 迄今临床和心理反应显著。

局限性

  • 仅为单例病例报告,证据级别有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hailey-Hailey disease (chronic benign familial pemphigus) is a rare inherited dermatosis typically characterized by erosions at intertriginous sites preceded by minor trauma or stress. We report a case of treatment-resistant Hailey-Hailey disease having failed topical and oral steroids, prophylactic aciclovir and doxycycline, and systemic therapies including dapsone, acitretin and ciclosporin. Low-dose naltrexone 4·5 mg once daily was commenced following an incidental benefit in this patient's similarly affected sister. The clinical and psychological response to date has been considerable.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Campbell V, McGrath C, Corry A, et al. Low-dose naltrexone: a novel treatment for Hailey-Hailey disease. Br J Dermatol. 2018. PMID: 28991360. doi:10.1111/bjd.16045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。